Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press ReleaseSee all News
Burrill & Company launches China Access Forums to provide gateway for North America Life Sciences companies to access China opportunitiesMarch 24, 2005
San Francisco, CA - March 24, 2005
To help North American life sciences companies capture the opportunities in China, Burrill & Company, a San Francisco-based leading life sciences merchant bank, with co-sponsors The BayHelix Group and China Access 2008, will launch nine half-day events, called China Access Forums, in nine major North American cities between March 28 and April 8, 2005. The first of the China Access Forums will be hosted by Burrill & Company in San Francisco on March 28, 2005.
The forums will focus on topics related to China life sciences, such as opportunities, challenges and trends in China, and how to bridge North America to China. With its tremendous cost advantages, a rapidly growing domestic market and quickly advancing science and technology, Greater China is fast becoming an important component in the worldwide life sciences landscape. The forums will involve respected world-class speakers, including industry leaders from China. This series of special business forums will be consciously structured to assist North American companies to better strategize the important commercial implications of the immediate evolving developments in China.
"We are excited to organize the China Access Forums with our co-sponsors and host the premiere event," noted G. Steven Burrill, CEO of Burrill & Company. "These forums will provide a unique interactive environment where industry leaders from both sides of the Pacific can directly communicate with each other," added Burrill.
The China Access Forums Schedule: March 28 - San Francisco, CA
March 30 - San Diego, CA
March 31 - Seattle, WA
April 1 - Vancouver, BC
April 4 - Edmonton, AB
April 5 - Toronto, ON
April 6 - Boston, MA
April 7 - New York, NY
April 8 - Washington, D.C.
"China Access Forums is an important part of our efforts to create a 'life sciences bridge' between North America and Greater China to enable trans-Pacific outsourcing and technology transfer," said Jonathan Wang, Burrill's General Manager for Greater China. "Burrill is well positioned to become a 'gateway' for North American companies to access the opportunities in Greater China, and vise versa."
About Burrill & Company
Burrill & Company is a life sciences merchant bank, focused exclusively on companies involved in biotechnology, pharmaceuticals, diagnostics, human healthcare and related medical technologies, wellness and nutraceuticals, agricultural technologies, and industrial biotechnology (biomaterials/bioprocesses).
The Burrill family of venture capital funds, with over $500 million under management, includes the Burrill Life Sciences Capital Fund, the Burrill Biotechnology Capital Fund, the Burrill Agbio Capital Fund and its successor-the Burrill Agbio Capital Fund II, and the Burrill Nutraceuticals Capital Fund. Burrill & Company has commenced its Burrill Life Sciences Capital Fund III, a $300-$500 million fund, which it expects to become operational in 2005.
Merchant Banking Services
Burrill & Company assists life science companies to identify, negotiate and close strategic partnerships and merger and acquisition transactions providing access to resources, technologies or collaborations essential for executing company business plans. We have completed 20 strategic partnerships with a value in excess of $1 billion. Service lines include:
- Strategic Partnering including licensing, research and other collaborations
- Strategic Advisory Services including new company formation
- Merger & Acquisitions across life sciences
- Spin-outs ranging from products, to research divisions to disease area franchises
Burrill & Company's annual analysis of the "State of the Industry" has been an important part of the biotech industry's view of itself over the last 19 years. Biotech 2005-Life Sciences: A Move Towards Predictability, is a perspective on where the industry has been and is going will be released Q1 05. In addition, the newly created Burrill Datacenter is an online resource for keeping up-to-date information from the biotech industry at your fingertips, including updated data from Biotech 2005. To order Biotech 2005 or to subscribe to the Burrill Datacenter, visit www.burrilldatacenter.com or call (415) 591-5400.
For more information, please visit Burrill & Company's website at www.burrillandco.com. Back to News list